Archive
Broadcast
About
A SERVICE OF OHIO'S PUBLIC BROADCASTING STATIONS
A SERVICE OF OHIO'S PUBLIC BROADCASTING STATIONS
Program Directory
All Sides with Ann Fisher - 12-14-2022 B - Wellness Wednesday - How active fatherhood alters brain functioning
Nearly 7 in 10 Americans support some form of paid-paternal leave, mostly with the idea that it's better for the newborn and fairer to both parents.
Research shows that the brains of involved fathers also can be affected.
The University of Southern California participated in a study that used magnetic resonance imaging to map how active fatherhood alters brain functioning.
Coming up on Wellness Wednesday, we talk about the science behind the study and why it matters.
Also on this Wellness Wednesday, 136 rural hospitals closed between 2010 and last year. The American Hospital Association cites a variety of causes. Bigger hospitals are willing to help, but it comes at a cost.
A new experimental Alzheimer's drug called Lecanemab is an exciting development for some, but others are concerned that the side effects may do more harm than good.
Dr. Madhav Thambisetty is a neurologist at the National Institute of Aging, which is part of the National Institutes of Health.
Guests:
Darby Saxbe, professor of psychology at the University of Southern California, co-director of the USC Center for the Changing Family
Brock Slabach, former rural hospital administrator and chief operations officer at the National Rural Health Association
Dr. Madhav Thambisetty, neurologist at the National Institute of Aging
Research shows that the brains of involved fathers also can be affected.
The University of Southern California participated in a study that used magnetic resonance imaging to map how active fatherhood alters brain functioning.
Coming up on Wellness Wednesday, we talk about the science behind the study and why it matters.
Also on this Wellness Wednesday, 136 rural hospitals closed between 2010 and last year. The American Hospital Association cites a variety of causes. Bigger hospitals are willing to help, but it comes at a cost.
A new experimental Alzheimer's drug called Lecanemab is an exciting development for some, but others are concerned that the side effects may do more harm than good.
Dr. Madhav Thambisetty is a neurologist at the National Institute of Aging, which is part of the National Institutes of Health.
Guests:
Darby Saxbe, professor of psychology at the University of Southern California, co-director of the USC Center for the Changing Family
Brock Slabach, former rural hospital administrator and chief operations officer at the National Rural Health Association
Dr. Madhav Thambisetty, neurologist at the National Institute of Aging
December 14, 2022